These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37873138)

  • 1. Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature.
    LaFlamme CW; Rastin C; Sengupta S; Pennington HE; Russ-Hall SJ; Schneider AL; Bonkowski ES; Almanza Fuerte EP; Galey M; Goffena J; Gibson SB; Allan TJ; Nyaga DM; Lieffering N; Hebbar M; Walker EV; Darnell D; Olsen SR; Kolekar P; Djekidel N; Rosikiewicz W; McConkey H; Kerkhof J; Levy MA; Relator R; Lev D; Lerman-Sagie T; Park KL; Alders M; Cappuccio G; Chatron N; Demain L; Genevieve D; Lesca G; Roscioli T; Sanlaville D; Tedder ML; Hubshman MW; Ketkar S; Dai H; Worley KC; Rosenfeld JA; Chao HT; ; Neale G; Carvill GL; ; Wang Z; Berkovic SF; Sadleir LG; Miller DE; Scheffer IE; Sadikovic B; Mefford HC
    medRxiv; 2023 Oct; ():. PubMed ID: 37873138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement.
    LaFlamme CW; Rastin C; Sengupta S; Pennington HE; Russ-Hall SJ; Schneider AL; Bonkowski ES; Almanza Fuerte EP; Allan TJ; Zalusky MP; Goffena J; Gibson SB; Nyaga DM; Lieffering N; Hebbar M; Walker EV; Darnell D; Olsen SR; Kolekar P; Djekidel MN; Rosikiewicz W; McConkey H; Kerkhof J; Levy MA; Relator R; Lev D; Lerman-Sagie T; Park KL; Alders M; Cappuccio G; Chatron N; Demain L; Genevieve D; Lesca G; Roscioli T; Sanlaville D; Tedder ML; Gupta S; Jones EA; Weisz-Hubshman M; Ketkar S; Dai H; Worley KC; Rosenfeld JA; Chao HT; ; Neale G; Carvill GL; ; Wang Z; Berkovic SF; Sadleir LG; Miller DE; Scheffer IE; Sadikovic B; Mefford HC
    Nat Commun; 2024 Aug; 15(1):6524. PubMed ID: 39107278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases.
    Kerkhof J; Rastin C; Levy MA; Relator R; McConkey H; Demain L; Dominguez-Garrido E; Kaat LD; Houge SD; DuPont BR; Fee T; Fletcher RS; Gokhale D; Haukanes BI; Henneman P; Hilton S; Hilton BA; Jenkinson S; Lee JA; Louie RJ; Motazacker MM; Rzasa J; Stevenson RE; Plomp A; van der Laan L; van der Smagt J; Walden KK; Banka S; Mannens M; Skinner SA; Friez MJ; Campbell C; Tedder ML; Alders M; Sadikovic B
    Genet Med; 2024 May; 26(5):101075. PubMed ID: 38251460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation episignature and comparative epigenomic profiling of HNRNPU-related neurodevelopmental disorder.
    Rooney K; van der Laan L; Trajkova S; Haghshenas S; Relator R; Lauffer P; Vos N; Levy MA; Brunetti-Pierri N; Terrone G; Mignot C; Keren B; de Villemeur TB; Volker-Touw CML; Verbeek N; van der Smagt JJ; Oegema R; Brusco A; Ferrero GB; Misra-Isrie M; Hochstenbach R; Alders M; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2023 Aug; 25(8):100871. PubMed ID: 37120726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically unresolved case of Rauch-Steindl syndrome diagnosed by its wolf-hirschhorn associated DNA methylation episignature.
    McConkey H; White-Brown A; Kerkhof J; Dyment D; Sadikovic B
    Front Cell Dev Biol; 2022; 10():1022683. PubMed ID: 36589751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders.
    Levy MA; Relator R; McConkey H; Pranckeviciene E; Kerkhof J; Barat-Houari M; Bargiacchi S; Biamino E; Palomares Bralo M; Cappuccio G; Ciolfi A; Clarke A; DuPont BR; Elting MW; Faivre L; Fee T; Ferilli M; Fletcher RS; Cherick F; Foroutan A; Friez MJ; Gervasini C; Haghshenas S; Hilton BA; Jenkins Z; Kaur S; Lewis S; Louie RJ; Maitz S; Milani D; Morgan AT; Oegema R; Østergaard E; Pallares NR; Piccione M; Plomp AS; Poulton C; Reilly J; Rius R; Robertson S; Rooney K; Rousseau J; Santen GWE; Santos-Simarro F; Schijns J; Squeo GM; John MS; Thauvin-Robinet C; Traficante G; van der Sluijs PJ; Vergano SA; Vos N; Walden KK; Azmanov D; Balci TB; Banka S; Gecz J; Henneman P; Lee JA; Mannens MMAM; Roscioli T; Siu V; Amor DJ; Baynam G; Bend EG; Boycott K; Brunetti-Pierri N; Campeau PM; Campion D; Christodoulou J; Dyment D; Esber N; Fahrner JA; Fleming MD; Genevieve D; Heron D; Husson T; Kernohan KD; McNeill A; Menke LA; Merla G; Prontera P; Rockman-Greenberg C; Schwartz C; Skinner SA; Stevenson RE; Vincent M; Vitobello A; Tartaglia M; Alders M; Tedder ML; Sadikovic B
    Hum Mutat; 2022 Nov; 43(11):1609-1628. PubMed ID: 35904121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation episignature for Witteveen-Kolk syndrome due to SIN3A haploinsufficiency.
    Coenen-van der Spek J; Relator R; Kerkhof J; McConkey H; Levy MA; Tedder ML; Louie RJ; Fletcher RS; Moore HW; Childers A; Farrelly ER; Champaigne NL; Lyons MJ; Everman DB; Rogers RC; Skinner SA; Renck A; Matalon DR; Dills SK; Monteleone B; Demirdas S; Dingemans AJM; Donker Kaat L; Kolk SM; Pfundt R; Rump P; Sadikovic B; Kleefstra T; Butler KM
    Genet Med; 2023 Jan; 25(1):63-75. PubMed ID: 36399132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders.
    Levy MA; McConkey H; Kerkhof J; Barat-Houari M; Bargiacchi S; Biamino E; Bralo MP; Cappuccio G; Ciolfi A; Clarke A; DuPont BR; Elting MW; Faivre L; Fee T; Fletcher RS; Cherik F; Foroutan A; Friez MJ; Gervasini C; Haghshenas S; Hilton BA; Jenkins Z; Kaur S; Lewis S; Louie RJ; Maitz S; Milani D; Morgan AT; Oegema R; Østergaard E; Pallares NR; Piccione M; Pizzi S; Plomp AS; Poulton C; Reilly J; Relator R; Rius R; Robertson S; Rooney K; Rousseau J; Santen GWE; Santos-Simarro F; Schijns J; Squeo GM; St John M; Thauvin-Robinet C; Traficante G; van der Sluijs PJ; Vergano SA; Vos N; Walden KK; Azmanov D; Balci T; Banka S; Gecz J; Henneman P; Lee JA; Mannens MMAM; Roscioli T; Siu V; Amor DJ; Baynam G; Bend EG; Boycott K; Brunetti-Pierri N; Campeau PM; Christodoulou J; Dyment D; Esber N; Fahrner JA; Fleming MD; Genevieve D; Kerrnohan KD; McNeill A; Menke LA; Merla G; Prontera P; Rockman-Greenberg C; Schwartz C; Skinner SA; Stevenson RE; Vitobello A; Tartaglia M; Alders M; Tedder ML; Sadikovic B
    HGG Adv; 2022 Jan; 3(1):100075. PubMed ID: 35047860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel.
    Sedlackova L; Sterbova K; Vlckova M; Seeman P; Zarubova J; Marusic P; Krsek P; Krijtova H; Musilova A; Lassuthova P
    Eur J Paediatr Neurol; 2024 Jan; 48():17-29. PubMed ID: 38008000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants.
    van der Laan L; Lauffer P; Rooney K; Silva A; Haghshenas S; Relator R; Levy MA; Trajkova S; Huisman SA; Bijlsma EK; Kleefstra T; van Bon BW; Baysal Ö; Zweier C; Palomares-Bralo M; Fischer J; Szakszon K; Faivre L; Piton A; Mesman S; Hochstenbach R; Elting MW; van Hagen JM; Plomp AS; Mannens MMAM; Alders M; van Haelst MM; Ferrero GB; Brusco A; Henneman P; Sweetser DA; Sadikovic B; Vitobello A; Menke LA
    HGG Adv; 2024 Jul; 5(3):100289. PubMed ID: 38571311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Insight into and Refinement of the Genomic Boundaries of the
    van der Laan L; Rooney K; Haghshenas S; Silva A; McConkey H; Relator R; Levy MA; Valenzuela I; Trujillano L; Lasa-Aranzasti A; Campos B; Castells N; Verberne EA; Maas S; Alders M; Mannens MMAM; van Haelst MM; Sadikovic B; Henneman P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762546
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of methylation episignatures in
    Lee S; Ochoa E; Barwick K; Cif L; Rodger F; Docquier F; Pérez-Dueñas B; Clark G; Martin E; Banka S; Kurian MA; Maher ER
    Epigenomics; 2022 May; 14(9):537-547. PubMed ID: 35506254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of the DNA methylation episignature for Duchenne muscular dystrophy.
    Schreyer L; Reilly J; McConkey H; Kerkhof J; Levy MA; Hu J; Hnaini M; Sadikovic B; Campbell C
    Neuromuscul Disord; 2023 Jan; 33(1):5-14. PubMed ID: 36572586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions.
    Aref-Eshghi E; Bend EG; Colaiacovo S; Caudle M; Chakrabarti R; Napier M; Brick L; Brady L; Carere DA; Levy MA; Kerkhof J; Stuart A; Saleh M; Beaudet AL; Li C; Kozenko M; Karp N; Prasad C; Siu VM; Tarnopolsky MA; Ainsworth PJ; Lin H; Rodenhiser DI; Krantz ID; Deardorff MA; Schwartz CE; Sadikovic B
    Am J Hum Genet; 2019 Apr; 104(4):685-700. PubMed ID: 30929737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.
    Bend EG; Aref-Eshghi E; Everman DB; Rogers RC; Cathey SS; Prijoles EJ; Lyons MJ; Davis H; Clarkson K; Gripp KW; Li D; Bhoj E; Zackai E; Mark P; Hakonarson H; Demmer LA; Levy MA; Kerkhof J; Stuart A; Rodenhiser D; Friez MJ; Stevenson RE; Schwartz CE; Sadikovic B
    Clin Epigenetics; 2019 Apr; 11(1):64. PubMed ID: 31029150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.
    Haghshenas S; Bhai P; Aref-Eshghi E; Sadikovic B
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants.
    Colin E; Duffourd Y; Tisserant E; Relator R; Bruel AL; Tran Mau-Them F; Denommé-Pichon AS; Safraou H; Delanne J; Jean-Marçais N; Keren B; Isidor B; Vincent M; Mignot C; Heron D; Afenjar A; Heide S; Faudet A; Charles P; Odent S; Herenger Y; Sorlin A; Moutton S; Kerkhof J; McConkey H; Chevarin M; Poë C; Couturier V; Bourgeois V; Callier P; Boland A; Olaso R; Philippe C; Sadikovic B; Thauvin-Robinet C; Faivre L; Deleuze JF; Vitobello A
    Front Cell Dev Biol; 2022; 10():1021785. PubMed ID: 36393831
    [No Abstract]   [Full Text] [Related]  

  • 18. Leveraging multiple approaches for the detection of pathogenic deep intronic variants in developmental and epileptic encephalopathies: A case report.
    Nyaga DM; Hildebrand MS; de Valles-Ibáñez G; Keenan NF; Ye Z; LaFlamme CW; Mefford HC; Bennett MF; Bahlo M; Sadleir LG
    Epilepsia Open; 2024 Apr; 9(2):758-764. PubMed ID: 38129960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene.
    Karimi K; Mol MO; Haghshenas S; Relator R; Levy MA; Kerkhof J; McConkey H; Brooks A; Zonneveld-Huijssoon E; Gerkes EH; Tedder ML; Vissers L; Salzano E; Piccione M; Asaftei SD; Carli D; Mussa A; Shukarova-Angelovska E; Trajkova S; Brusco A; Merla G; Alders MM; Bouman A; Sadikovic B
    Genet Med; 2024 Mar; 26(3):101041. PubMed ID: 38054406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation episignatures: insight into copy number variation.
    van der Laan L; Rooney K; Trooster TM; Mannens MM; Sadikovic B; Henneman P
    Epigenomics; 2022 Nov; 14(21):1373-1388. PubMed ID: 36537268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.